What conditions cause periventricular leukomalacia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Conditions Causing Periventricular Leukomalacia

Periventricular leukomalacia (PVL) is primarily caused by hypoxic-ischemic injury to the developing white matter in premature infants, with intraventricular hemorrhage being the strongest associated condition, followed by infection/inflammation, hemodynamic instability, and lack of protective interventions like antenatal corticosteroids.

Primary Causative Mechanisms

Hypoxic-Ischemic Injury

The fundamental pathophysiology involves cerebral hypoperfusion and hypoxia-ischemia affecting the vulnerable periventricular white matter, particularly in premature infants with immature cerebrovascular autoregulation 1. This occurs most commonly during mid-to-late gestation when oligodendrocyte precursors are most susceptible to injury.

Strongest Associated Condition

Intraventricular hemorrhage (IVH) has the strongest evidence-based association with PVL, with an adjusted odds ratio of 3.22 (moderate certainty of evidence) 2. Specifically, Papile grade III or IV IVH significantly increases PVL risk, with 69% of children with grade 2-3 PVL having severe IVH 3.

Major Risk Factors by Category

Maternal/Placental Factors:

  • Chorioamnionitis and intrauterine infection - inflammatory cytokines (TNF-alpha, IL-6) directly damage oligodendrocyte precursors 2, 1
  • Preterm premature rupture of membranes (PPROM) >48 hours 2
  • Lack of antenatal corticosteroids - steroids reduce PVL incidence at 23-25 weeks gestation 4, 2
  • Antenatal indomethacin exposure 2
  • Multifetal pregnancy reduction 2

Intrapartum/Perinatal Factors:

  • Perinatal asphyxia 2
  • Recurrent late decelerations on fetal heart rate monitoring (OR 3.57) - indicates fetal acidosis 5
  • Loss of fetal heart rate variability (OR not calculable but significant) 5
  • Birth trauma 1

Neonatal/Postnatal Factors:

Hemodynamic instability:

  • Late-onset circulatory collapse/dysfunction (OR 3.41) 2, 5
  • Shock/hypotension 2
  • Patent ductus arteriosus requiring surgical ligation 2

Respiratory complications:

  • Mechanical ventilation (though association strength has decreased over time with improved strategies) 2
  • Hypocarbia - excessive CO2 removal causes cerebral vasoconstriction 2
  • Respiratory failure 1

Infectious/inflammatory:

  • Neonatal sepsis 2
  • Necrotizing enterocolitis 2

Other:

  • Neonatal surgery 2
  • Cardiopulmonary defects 1

Critical Pathophysiologic Insight

The vulnerability of premature oligodendrocyte precursors is central - these cells are highly susceptible to:

  • Glutamate excitotoxicity
  • Free radical damage
  • Proinflammatory cytokines (TNF-alpha, IL-6)
  • Lack of trophic support

Microglial and astrocytic activation amplifies injury through release of inflammatory mediators 6, 1.

Important Clinical Caveats

The topography of PVL lesions reflects the combination of:

  1. Immature cerebrovascular development in watershed zones
  2. Failure of cerebral blood flow autoregulation during hypoxic-ischemic insults
  3. Peak vulnerability period around mid-to-late gestation

Guideline-supported protective interventions that reduce PVL risk include:

  • Antenatal corticosteroids at 23-25 weeks gestation 4
  • Magnesium sulfate for neuroprotection before anticipated periviable delivery 4
  • Broad-spectrum antibiotics for PPROM at ≥24 weeks 4

The certainty of evidence remains low to very low for most risk factors despite decades of research, with the notable exception of IVH (moderate certainty) 2.

References

Research

Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system.

Neuropathology : official journal of the Japanese Society of Neuropathology, 2002

Guideline

periviable birth: interim update.

American Journal of Obstetrics and Gynecology, 2016

Research

Assessment of risk factors for cystic periventricular leukomalacia.

The journal of obstetrics and gynaecology research, 2020

Research

Progress in periventricular leukomalacia.

Archives of neurology, 2008

Related Questions

What is the pathogenesis of periventricular leukomalacia (PVL) in preterm infants born before 32 weeks of gestation and how does it compromise long-term neurodevelopment?
What is the management of Periventricular Leukomalacia (PVL)?
What is most strongly supported by a diagnosis of periventricular leukomalacia and symptoms of scissoring of the legs when held upright?
How should periventricular leukomalacia be managed in an adult?
What is leukomalacia in the context of brain injury or disease, particularly for a patient with chronic microvascular ischemic changes and a Dandy-Walker variant?
What is the maximum recommended daily dose of Adderall XR (mixed amphetamine salts extended‑release) and the combined maximum dose when used with Adderall IR (immediate‑release)?
How should a 42-year-old female with recent chemotherapy, hypertension, orthostatic hypotension, type 1 diabetes, iron‑deficiency anemia, nephrolithiasis, and recent urinary tract infection who presents with bilateral flank pain, fever, hypotension, dry mucous membranes, costovertebral tenderness, and urinalysis showing leukocytes, blood, protein, and glucose be managed acutely?
Which estrogen—estradiol or estrone—is preferred for menopausal hormone therapy, and what are the reasons for this preference?
In a patient who had a hysterectomy 43 years ago with a retained fallopian tube and adhesions removed, what symptoms might the retained tube cause?
Should I administer intravenous pantoprazole (Pantoprazole) for a possible gastrointestinal bleed?
What are the causes of low left ventricular filling pressure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.